Effect of Nanoparticle Rigidity on the Interaction of Stromal Membrane Particles with Leukemia Cells

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Hematology

Background:

• Acute myeloid leukemia (AML) relapse is driven by therapy-resistant leukemic stem cells.
• Leukemic stem cells associate with bone marrow stromal cells, increasing drug resistance.
• Developing novel strategies to target these resistant cells is crucial.

Purpose of the Study:

• To investigate the interaction of cell membrane nanoparticles (CM-Liposomes) with AML cells.
• To explore how nanoparticle rigidity influences cellular uptake.
• To assess the potential of CM-Liposomes for AML therapy.

Main Methods:

• Preparation of cell membrane liposomes (CM-Liposomes) with varying charges.
• Deposition of CM-Liposomes onto silica cores to create rigid nanoparticles.
• Characterization using dynamic light scattering (DLS), cryo-electron microscopy (Cryo-EM), and atomic force microscopy (AFM).
• Assessment of nanoparticle uptake by leukemic cells, including primary patient cells.

Main Results:

• Nanoparticle rigidity, achieved by deposition on silica cores, significantly increased uptake by AML cells.
• Soft CM-Liposomes showed no difference in uptake compared to standard liposomes.
• Preliminary results with primary leukemia cells corroborated the enhanced uptake of rigid CM-Liposomes.

Conclusions:

• Nanoparticle rigidity is a critical factor influencing the interaction and uptake by targeted leukemic cells.
• Rigid cell membrane nanoparticles show promise for enhanced drug delivery in AML treatment.
• This study provides insights into optimizing nanoparticle design for targeting resistant cancer stem cells.